Discontinuation report TEVA-LISINOPRIL (TYPE P)

Last updated on 2018-10-12 History
Report ID 63978
Drug Identification Number 02285096
Brand name TEVA-LISINOPRIL (TYPE P)
Common or Proper name LISINOPRIL (TYPE P)
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LISINOPRIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-06-30
Remaining supply date 2018-08-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-10-12 French Compare
v2 2018-10-12 English Compare
v1 2018-10-12 English Compare